AllPennyStocks.com SLS Stock Rises Overnight: Healthcare Execs Tout AML Drug As ‘Game Changer’ Ahead Of Final Trial Trigger
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

SLS Stock Rises Overnight: Healthcare Execs Tout AML Drug As ‘Game Changer’ Ahead Of Final Trial Trigger

An AstraZeneca sales executive called the Phase 3 Regal trial a “game changer” for AML patients in their first or second complete remission.

Other Penny Stock Movers

Fake Players Are Shaping How Games Get Reviewed; This Microcap Just Got Hired to Prove It
Copper's Real Constraint Isn't Demand. It's Ground
Colombian Oil Producer Jumps as Q2 Revenue More Than Doubles
Most Popular
{{ index + 1 }}


Back to Top